Bacillus Calmette-Guérin vaccination in preterm infants

International Journal of Tuberculosis and Lung Disease

Volumn 10, Issue 12, 2006, Pages 1337-1341

  Okan, Fusun ^a,b   Karagoz, S ^a   Nuhoglu, A ^a  

^a Sisli Children's Hospital   (Turkey)

^b SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

BCG; Preterm infants; Tuberculin skin test

Indexed keywords

BCG VACCINE; TUBERCULIN;

ABSCESS; ARTICLE; BCG VACCINATION; BIRTH WEIGHT; CHILD CARE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN EXPERIMENT; INFANT; MALE; NORMAL HUMAN; POSTNATAL CARE; PREMATURITY; PRENATAL GROWTH; PRIORITY JOURNAL; PROPHYLAXIS; SKIN INDURATION; SKIN ULCER; TUBERCULIN TEST; TUBERCULOSIS; TURKEY (REPUBLIC); WEIGHT GAIN; IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; LUNG TUBERCULOSIS; NEWBORN; VACCINATION;

BCG VACCINE; BIRTH WEIGHT; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INJECTIONS, INTRADERMAL; MALE; TUBERCULIN; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; VACCINATION;

EID: 33845515273     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Fine P E M, Carnerio I A M, Milstien J B, Clements C J. Issues related to the use of BCG in immunization programmes. WHO/V&B/99.23. Geneva, Switzerland: World Health Organization, 1999.
2. Colditz G A, Berkey C S, Mollester F, et al. Efficacy of BCG vaccination of newborns and infants in the prevention of tuberculosis: meta-analysis of the published literature. Pediatrics 1995; 1: 29-35.
3. al-Kassimi F A, al-Hajjaj M S, al-Orainey I O, et al. Does the protective effect of neonatal BCG correlate with vaccine-induced tuberculin reaction? Am J Respir Crit Care Med 1995; 152: 1575-1578.
4. Manerikar S S, Malavia A N, Singh M, et al. Immune status and BCG vaccination in newborns with intrauterine growth retardation. Clin Exp Immunol 1997; 26: 173-175.
5. Dawodu A H. Tuberculin conversion following BCG vaccination in preterm infants. Acta Paediatr Scand 1985; 74: 564-567.
6. Thayyil-Sudhan S, Kumar A, Singh M, Paul V K, Deorari A K. Safety and effectiveness of BCG vaccination in preterm babies. Arch Dis Child Fetal Neonatal Ed 1999; 81: F64-F66.
7. Sedaghatian M R, Kardouni K. Tuberculin response in preterm infants after BCG vaccination at birth. Arch Dis Child 1993; 69: 309-311.
8. Sedaghatian M R, Hashem F, Hossain M M. Bacille Calmette-Guérin vaccination in pre-term infants. Int J Tuberc Lung Dis 1998; 2: 679-682.
9. Ferreira A A, Bunn M M, Anna C S S, Ferreira M F C. BCG vaccination in low birth weight new-borns: analysis of lymphocyte proliferation, IL-2 generation and intradermal reaction to PPD. Tubercle Lung Dis 1996; 77: 476-481.
10. Myat Tun K, Win H, Kyaw A O, et al. Tuberculin conversion after BCG vaccination: comparison by gestation and by age at immunization in Myanmar. Trans R Soc Trop Med Hyg 2000; 94: 219-220.
11. Ildirim İ, Sapan N, Çavuşoǧlu B. Comparison of BCG vaccination at birth and at third month of life. Arch Dis Child 1992; 67: 80-82.
12. Ballard J L, Khourjy J C, Wedig K, Wang L, Ellers-Walsman B L, Lipp R. New Ballard score expanded to include extremely premature infants. J Pediatr 1991; 119: 417-423.
13. Lubchenko L O, Hansman C, Boyd E. Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26-40 weeks. Pediatrics 1966; 37: 403-408.
14. World Health Organization, Global Tubeculosis Programme and Global Programme on Vaccines. Statement on BCG revaccination for the prevention of tuberculosis. Wkly Epidemiol Rec 1995; 72: 229-231.
15. Lord Chan of Oxton. Special problems in developing countries. In: Rennie J M, ed. Roberton's Textbook of Neonatology. 4th ed. Philadelphia, PA, USA: Elsevier, Churchill Livingstone, 2005: 113-120.
16. Sari T M. Immunization of preterm and low birth weight infants. Pediatrics 2003; 112: 193-198.
17. American Academy of Pediatrics, Comittee on Infectious Diseases. Immunization in special clinical circumstances. Preterm infants. In: Pickering L K, ed. 26th ed. Red Book: 2003 Report of the Committee on Infectious Diseases. Elk Grove Village, IL, USA: American Academy of Pediatrics 2003: 66-68.
18. Davis R L, Rubanowice D, Shinefield H R, et al. Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization status. Centers for Disease Control and Prevention, Vaccine Safety Datalink Group. JAMA 1999; 282: 547-553.
19. Langkamp D L, Hoshaw-Woodard S, Boye M E, et al. Delays in receipt of immunizations in low-birth-weight children: a nationally representative sample. Arch Pediatr Adolesc Med 2001; 155: 167-172.
20. Roth A, Jensen H, Garly M L, et al. Low birth weight infants and Calmette-Guérin vaccination at birth: community study from Guinea-Bissau. Pediatr Infect Dis J 2004; 23: 544-547.
21. Tastan A, Arvas A, Demir G, Alikasifoglu M, Gur E, Kiray E. Influence of Bacillus Calmette-Guérin vaccination at birth and 2 months old age on the peripheral blood T-cell subpopulations (gamma/delta and alpha-beta T cell). Pediatr Allergy Immunol 2005; 16: 624-629.
22. Kaur S, Faridi M M, Agarwal K N. BCG vaccination reaction in low birth weight infants. Indian J Med Res 2002; 116: 64-69.